A novel tool that embeds 3Rs principles in multiple sclerosis research.
一种将 3R 原则融入多发性硬化症研究的新颖工具。
基本信息
- 批准号:2338125
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:英国
- 项目类别:Studentship
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The context of the research: Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults in Europe and North America. This debilitating disease is modelled in animals by inducing CNS autoimmunity in which the animal's defence system against bacteria and viruses, instead attacks cells in the animal's CNS. This results in experimental autoimmune encephalomyelitis (EAE); a condition characterised by paralysis in the experimental animal. Thus, EAE is classed as severe under the Animals (Scientific Procedures) Act 1986. Although EAE has helped us understand aspects of MS and informed drug discovery and testing, there is an urgent need to find an alternative that eliminates or reduces its use. Here we will develop and verify a cell culture (brain in a dish) model of EAE to replace experiments in living animals.Aims and objectives: With our combined expertise in EAE, myelinating cell cultures, axon degeneration and electrophysiology, we will provide a validated cell culture tool to: * model of EAE/MS using embryonic mice, that (i) reduces the use of EAE by the research and pharmaceutical communities (ii) will be used to generate new concepts, ideas, toxicity screening and target validation and (iii) to investigate how axons are injured and can be rescued in the context of progressive MS.* publicise this model to maximise its uptake * provide training in the 3Rs principles in general, and in the context of understanding, investigating and identifying therapies for neurodegenerative disorders.* instil a long-term appreciation and adoption of the 3Rs principles* elucidate the mechanisms and molecules responsible for axon injury, providing rationale targets for therapeutic intervention* provide mentoring and training in many skills, including adoption of rigorous and unbiased approaches to addressing research questions
研究背景:多发性硬化症(MS)是欧洲和北美年轻人非创伤性神经功能障碍的最常见原因。这种使人衰弱的疾病通过诱导CNS自身免疫在动物中建模,其中动物针对细菌和病毒的防御系统攻击动物CNS中的细胞。这导致实验性自身免疫性脑脊髓炎(EAE);一种以实验动物瘫痪为特征的病症。因此,根据1986年动物(科学程序)法案,EAE被归类为重度。尽管EAE帮助我们了解了MS的各个方面,并为药物发现和测试提供了信息,但迫切需要找到一种消除或减少其使用的替代品。在这里,我们将开发和验证细胞培养目的和目标:凭借我们在EAE、髓鞘细胞培养、轴突变性和电生理学方面的综合专业知识,我们将提供一种经过验证的细胞培养工具,以:* 使用胚胎小鼠的EAE/MS模型,(i)减少研究和制药界对EAE的使用(ii)将用于产生新的概念,想法,毒性筛选和靶点验证,以及(iii)研究轴突是如何受损的,以及在进行性MS的背景下如何获救。宣传这一模型,以最大限度地提高其吸收率 * 提供一般3R原则的培训,并在理解,调查和确定神经退行性疾病治疗方法的背景下提供培训。灌输对3R原则的长期理解和采用 * 阐明轴突损伤的机制和分子,为治疗干预提供合理目标 * 提供许多技能的指导和培训,包括采用严格和公正的方法来解决研究问题
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
-- - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
相似海外基金
I-Corps: Translation Potential of an Objective and Customizable Concussion Assessment and Rehabilitation Tool for Specialized Populations
I-Corps:针对特殊人群的客观且可定制的脑震荡评估和康复工具的转化潜力
- 批准号:
2348910 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Collaborative Research: EAGER: The next crisis for coral reefs is how to study vanishing coral species; AUVs equipped with AI may be the only tool for the job
合作研究:EAGER:珊瑚礁的下一个危机是如何研究正在消失的珊瑚物种;
- 批准号:
2333604 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Capacity Assessment, Tracking, & Enhancement through Network Analysis: Developing a Tool to Inform Capacity Building Efforts in Complex STEM Education Systems
能力评估、跟踪、
- 批准号:
2315532 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The development and evaluation of a digital role playing game (RPG) as a tool to support foreign language learning
作为支持外语学习工具的数字角色扮演游戏(RPG)的开发和评估
- 批准号:
24K04095 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Screen4SpLDs - Development of an Automated Pre-Screening Tool for Specific Learning Disabilities in Children.
Screen4SpLDs - 开发针对儿童特定学习障碍的自动预筛查工具。
- 批准号:
EP/Y002121/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Automating a novel multi-tool additive and subtractive manufacturing platform for micrometre-resolution prototyping across diverse industries
自动化新型多工具增材和减材制造平台,用于跨不同行业的微米分辨率原型制作
- 批准号:
10097846 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
HoloSurge: Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时指导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
- 批准号:
10103131 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
N2Vision+: A robot-enabled, data-driven machine vision tool for nitrogen diagnosis of arable soils
N2Vision:一种由机器人驱动、数据驱动的机器视觉工具,用于耕地土壤的氮诊断
- 批准号:
10091423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
LeicSurvey: A digital survey tool for the heritage sector
LeicSurvey:遗产部门的数字调查工具
- 批准号:
ES/Y011147/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
-- - 项目类别:














{{item.name}}会员




